Corix Bioscience (Corix Bioscience) Change In Payables And Accrued Expense : $-0.03 Mil (TTM As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Change In Payables And Accrued Expense?

Corix Bioscience's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2017 was $-0.79 Mil. It means Corix Bioscience's Accounts Payable & Accrued Expense declined by $0.79 Mil from Jun. 2017 to Sep. 2017 .

Corix Bioscience's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2016 was $0.09 Mil. It means Corix Bioscience's Accounts Payable & Accrued Expense increased by $0.09 Mil from Jan. 2015 to Dec. 2016 .

Corix Bioscience Change In Payables And Accrued Expense Historical Data

The historical data trend for Corix Bioscience's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Change In Payables And Accrued Expense Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.06

0.01

0.02

0.09

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.03	-	0.04	0.72	-0.79

Corix Bioscience Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

Corix Bioscience Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines